186 related articles for article (PubMed ID: 35585988)
1. pcMSC Modulates Immune Dysregulation in Patients With COVID-19-Induced Refractory Acute Lung Injury.
Chen MC; Lai KS; Chien KL; Teng ST; Lin YR; Chao W; Lee MJ; Wei PL; Huang YH; Kuo HP; Weng CM; Chou CL
Front Immunol; 2022; 13():871828. PubMed ID: 35585988
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H
Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial.
Kaffash Farkhad N; Sedaghat A; Reihani H; Adhami Moghadam A; Bagheri Moghadam A; Khadem Ghaebi N; Khodadoust MA; Ganjali R; Tafreshian AR; Tavakol-Afshari J
Stem Cell Res Ther; 2022 Jun; 13(1):283. PubMed ID: 35765103
[TBL] [Abstract][Full Text] [Related]
5. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).
Ye Q; Wang H; Xia X; Zhou C; Liu Z; Xia ZE; Zhang Z; Zhao Y; Yehenala J; Wang S; Zhou G; Hu K; Wu B; Wu CT; Wang S; He Y
Trials; 2020 Jun; 21(1):520. PubMed ID: 32532356
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Therapeutic Plasma Exchange in Severe Acute Respiratory Distress Syndrome in COVID-19 Patients from the Western Part of Romania.
Porosnicu TM; Gindac C; Popovici S; Marinescu A; Jipa D; Lazaroiu V; Sandesc D; Oancea C; Folescu R; Zamfir AS; Zamfir CL; Nussbaum LA; Sirbu IO
Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556909
[TBL] [Abstract][Full Text] [Related]
8. The Systematic Effect of Mesenchymal Stem Cell Therapy in Critical COVID-19 Patients: A Prospective Double Controlled Trial.
Adas G; Cukurova Z; Yasar KK; Yilmaz R; Isiksacan N; Kasapoglu P; Yesilbag Z; Koyuncu ID; Karaoz E
Cell Transplant; 2021; 30():9636897211024942. PubMed ID: 34180719
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulatory and Anti-fibrotic Effects Following the Infusion of Umbilical Cord Mesenchymal Stromal Cells in a Critically Ill Patient With COVID-19 Presenting Lung Fibrosis: A Case Report.
da Silva KN; Pinheiro PCG; Gobatto ALN; Passos RDH; Paredes BD; França LSA; Nonaka CKV; Barreto-Duarte B; Araújo-Pereira M; Tibúrcio R; Cruz FF; Martins GLS; Andrade BB; de Castro-Faria-Neto HC; Rocco PRM; Souza BSF
Front Med (Lausanne); 2021; 8():767291. PubMed ID: 34869480
[No Abstract] [Full Text] [Related]
10. The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect.
Can A; Coskun H
Stem Cells Transl Med; 2020 Nov; 9(11):1287-1302. PubMed ID: 32779878
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of TGFβ1 in murine mesenchymal stem cells improves lung inflammation by impacting the Th17/Treg balance in LPS-induced ARDS mice.
Chen J; Zhang X; Xie J; Xue M; Liu L; Yang Y; Qiu H
Stem Cell Res Ther; 2020 Jul; 11(1):311. PubMed ID: 32698911
[TBL] [Abstract][Full Text] [Related]
12. Continuous renal replacement therapy with the addition of CytoSorb cartridge in critically ill patients with COVID-19 plus acute kidney injury: A case-series.
Alharthy A; Faqihi F; Memish ZA; Balhamar A; Nasim N; Shahzad A; Tamim H; Alqahtani SA; Brindley PG; Karakitsos D
Artif Organs; 2021 May; 45(5):E101-E112. PubMed ID: 33190288
[TBL] [Abstract][Full Text] [Related]
13. Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS).
Hashemian SM; Shafigh N; Afzal G; Jamaati H; Tabarsi P; Marjani M; Malekmohammad M; Mortazavi SM; Khoundabi B; Mansouri D; Moniri A; Hajifathali A; Roshandel E; Mortaz E; Adcock IM
Pulmonology; 2021; 27(6):486-492. PubMed ID: 33358260
[TBL] [Abstract][Full Text] [Related]
14. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
[TBL] [Abstract][Full Text] [Related]
15. Curcumin regulates the differentiation of naïve CD4+T cells and activates IL-10 immune modulation against acute lung injury in mice.
Chai YS; Chen YQ; Lin SH; Xie K; Wang CJ; Yang YZ; Xu F
Biomed Pharmacother; 2020 May; 125():109946. PubMed ID: 32004976
[TBL] [Abstract][Full Text] [Related]
16. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
[TBL] [Abstract][Full Text] [Related]
17. MSC-NTF (NurOwn®) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model.
Kaspi H; Semo J; Abramov N; Dekel C; Lindborg S; Kern R; Lebovits C; Aricha R
Stem Cell Res Ther; 2021 Jan; 12(1):72. PubMed ID: 33468250
[TBL] [Abstract][Full Text] [Related]
18. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of the effects of immunotherapy and mesenchymal stem cells transplantation in the treatment of critically ill coronavirus disease 2019 patients].
Yan Y; Jiang X; Ding D; Huang J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb; 33(2):139-144. PubMed ID: 33729129
[TBL] [Abstract][Full Text] [Related]
20. Current status of mesenchymal stem cell therapy for immune/inflammatory lung disorders: Gleaning insights for possible use in COVID-19.
Yen BL; Yen ML; Wang LT; Liu KJ; Sytwu HK
Stem Cells Transl Med; 2020 Oct; 9(10):1163-1173. PubMed ID: 32526079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
